Petros Pharmaceuticals, Inc. Cash Provided by (Used in) Financing Activities, Discontinued Operations
Petros Pharmaceuticals, Inc. (PTPI) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of -$765.28 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2026-04-15
- Petros Pharmaceuticals, Inc. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-12-31 was $0.00.
- Petros Pharmaceuticals, Inc. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2024-09-30 was -$385.49K.
- Petros Pharmaceuticals, Inc. cash provided by (used in) financing activities, discontinued operations for fiscal 2024 was -$765.28K.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$385.49K derived: sum of 2 quarters · filed 2026-04-15 | -$765.28K 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$385.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$765.28K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$379.79K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |